Trials / Conditions / Atypical Hyperplasia
Atypical Hyperplasia
5 registered clinical trials studyying Atypical Hyperplasia — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometri NCT06073184 | University Health Network, Toronto | Phase 2 |
| Recruiting | Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometriu NCT04008563 | University Health Network, Toronto | N/A |
| Completed | Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepitheli NCT03300557 | National Cancer Institute (NCI) | Phase 2 |
| Completed | OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer NCT01961102 | Krankenhaus Barmherzige Schwestern Linz | — |
| Active Not Recruiting | Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up NCT01357772 | Andrea DeCensi | Phase 3 |